Daymark Wealth Partners LLC Sells 750 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Daymark Wealth Partners LLC cut its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,600 shares of the exchange traded fund’s stock after selling 750 shares during the period. Daymark Wealth Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,632,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of XBI. Dimension Capital Management LLC increased its stake in SPDR S&P Biotech ETF by 28.5% in the 2nd quarter. Dimension Capital Management LLC now owns 15,311 shares of the exchange traded fund’s stock worth $1,419,000 after buying an additional 3,396 shares in the last quarter. Employees Retirement System of Texas boosted its stake in shares of SPDR S&P Biotech ETF by 40.8% in the second quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after acquiring an additional 174,857 shares during the period. Affinity Asset Advisors LLC grew its position in shares of SPDR S&P Biotech ETF by 105.4% during the second quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after purchasing an additional 737,550 shares in the last quarter. Prairie Wealth Advisors Inc. raised its stake in SPDR S&P Biotech ETF by 3.6% during the 2nd quarter. Prairie Wealth Advisors Inc. now owns 6,616 shares of the exchange traded fund’s stock valued at $613,000 after purchasing an additional 231 shares during the period. Finally, Toronto Dominion Bank lifted its holdings in SPDR S&P Biotech ETF by 16.3% in the 2nd quarter. Toronto Dominion Bank now owns 21,743 shares of the exchange traded fund’s stock worth $2,016,000 after purchasing an additional 3,048 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $98.18 on Friday. The company has a market capitalization of $7.48 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The business has a 50 day simple moving average of $98.92 and a two-hundred day simple moving average of $93.96.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.